Healthcare Sector Stocks
The Healthcare sector has a total of 1059 stocks, with a combined market cap of $8.33 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.43.
Market Cap
8.33T
Revenue
4.59T
Profits
201.12B
PE Ratio
41.43
Profit Margin
4.38%
Dividend Yield
0.43%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 949.47B | -0.02% | 2,983,414 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 554.09B | -1.21% | 6,623,642 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 376.54B | -1.20% | 4,709,783 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 342.24B | -2.99% | 6,498,144 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 295.69B | -2.20% | 10,012,129 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 291.04B | 0.09% | 1,412,138 | 60.44B |
| 7 | NVS | Novartis AG | 287.58B | -0.80% | 1,047,358 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 198.14B | -1.71% | 9,355,691 | 50.57B |
| 9 | AMGN | Amgen Inc. | 181.31B | -0.99% | 1,860,952 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 166.55B | -0.02% | 1,942,607 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 166.04B | -0.47% | 6,409,619 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 154.64B | -0.33% | 1,690,749 | 10.58B |
| 13 | ABT | Abbott Laboratories | 150.96B | -0.85% | 10,253,936 | 45.13B |
| 14 | PFE | Pfizer Inc. | 147.33B | -0.19% | 29,084,738 | 63.32B |
| 15 | DHR | Danaher Corporation | 122.31B | 0.47% | 3,283,250 | 24.78B |
| 16 | SYK | Stryker Corporation | 119.99B | -1.10% | 2,834,746 | 25.27B |
| 17 | BMY | Bristol-Myers Squibb Company | 118.50B | -2.40% | 8,161,596 | 48.48B |
| 18 | CVS | CVS Health Corporation | 115.76B | -2.71% | 5,624,429 | 405.62B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 110.64B | 0.32% | 865,853 | 12.22B |
| 20 | SNY | Sanofi | 106.43B | -0.32% | 2,538,354 | 54.60B |
| 21 | GSK | GSK plc | 103.29B | 0.23% | 2,835,528 | 43.29B |
| 22 | MDT | Medtronic plc | 99.63B | -1.27% | 6,704,215 | 35.48B |
| 23 | MCK | McKesson Corporation | 90.68B | -1.52% | 1,978,183 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 87.05B | -0.42% | 1,091,681 | 76.39B |
| 25 | BSX | Boston Scientific Corporation | 85.67B | -0.24% | 15,258,397 | 20.61B |
| 26 | ELV | Elevance Health, Inc. | 84.23B | -1.73% | 1,518,776 | 200.42B |
| 27 | CI | The Cigna Group | 74.29B | -1.89% | 2,321,897 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 64.57B | -0.67% | 889,901 | 14.92B |
| 29 | COR | Cencora, Inc. | 52.68B | -1.50% | 1,343,262 | 328.68B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 50.84B | -2.34% | 3,374,943 | 28.34B |
| 31 | EW | Edwards Lifesciences Corporation | 50.41B | 2.05% | 5,116,414 | 6.30B |
| 32 | ARGX | argenx SE | 50.16B | 0.24% | 167,907 | 4.74B |
| 33 | MDLN | Medline Inc. | 47.50B | -2.30% | 14,711,345 | 29.14B |
| 34 | CAH | Cardinal Health, Inc. | 46.93B | -0.15% | 1,714,940 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 43.95B | -0.39% | 425,115 | 4.45B |
| 36 | HLN | Haleon plc | 40.72B | -0.54% | 10,078,450 | 14.85B |
| 37 | BDX | Becton, Dickinson and Company | 40.71B | 0.08% | 3,243,506 | 22.23B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 40.30B | 1.58% | 4,445,478 | 17.35B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.45B | -0.66% | 649,732 | 4.29B |
| 40 | HUM | Humana Inc. | 36.22B | -2.03% | 698,135 | 137.20B |
| 41 | ZTS | Zoetis Inc. | 33.63B | -1.34% | 5,697,058 | 9.53B |
| 42 | ONC | BeOne Medicines AG | 33.62B | -2.52% | 206,193 | 5.70B |
| 43 | WAT | Waters Corporation | 33.25B | -1.09% | 594,662 | 3.77B |
| 44 | RVMD | Revolution Medicines, Inc. | 32.93B | 2.20% | 2,393,479 | - |
| 45 | ALC | Alcon Inc. | 32.90B | -0.12% | 2,288,826 | 10.63B |
| 46 | A | Agilent Technologies, Inc. | 32.52B | 0.10% | 2,839,371 | 7.07B |
| 47 | RPRX | Royalty Pharma plc | 31.01B | -1.17% | 2,758,477 | 2.44B |
| 48 | RMD | ResMed Inc. | 30.17B | -0.03% | 1,695,175 | 5.54B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 29.19B | -0.08% | 4,018,808 | 20.98B |
| 50 | NTRA | Natera, Inc. | 28.77B | -1.12% | 1,466,530 | 2.50B |
| 51 | BIIB | Biogen Inc. | 28.51B | -0.35% | 930,213 | 9.94B |
| 52 | CNC | Centene Corporation | 28.25B | -3.26% | 4,260,052 | 178.33B |
| 53 | DXCM | DexCom, Inc. | 27.79B | -0.12% | 5,311,989 | 4.82B |
| 54 | IQV | IQVIA Holdings Inc. | 27.04B | -3.51% | 2,005,349 | 16.63B |
| 55 | VEEV | Veeva Systems Inc. | 25.87B | -1.02% | 2,255,492 | 3.20B |
| 56 | PHG | Koninklijke Philips N.V. | 25.64B | -0.04% | 1,103,181 | 20.34B |
| 57 | UTHR | United Therapeutics Corporation | 24.55B | 1.76% | 965,712 | 3.17B |
| 58 | INSM | Insmed Incorporated | 23.60B | 2.48% | 2,273,665 | 819.56M |
| 59 | BNTX | BioNTech SE | 23.33B | 0.12% | 587,706 | 3.23B |
| 60 | WST | West Pharmaceutical Services, Inc. | 22.34B | -0.08% | 477,758 | 3.22B |
| 61 | MTD | Mettler-Toledo International Inc. | 22.26B | -0.16% | 169,188 | 4.09B |
| 62 | ILMN | Illumina, Inc. | 21.97B | 0.56% | 1,602,589 | 4.39B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.35B | -1.19% | 869,413 | 11.28B |
| 64 | ROIV | Roivant Sciences Ltd. | 21.34B | -0.98% | 7,294,256 | 8.26M |
| 65 | STE | STERIS plc | 21.21B | -0.14% | 682,390 | 5.94B |
| 66 | LH | Labcorp Holdings Inc. | 21.19B | -0.57% | 636,434 | 14.14B |
| 67 | INCY | Incyte Corporation | 19.40B | -0.06% | 1,176,044 | 5.36B |
| 68 | VTRS | Viatris Inc. | 18.94B | -2.34% | 11,437,174 | 14.56B |
| 69 | MRNA | Moderna, Inc. | 18.66B | 0.32% | 3,997,619 | 2.23B |
| 70 | GMAB | Genmab A/S | 16.56B | 0.07% | 1,020,510 | 3.90B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 16.33B | -1.27% | 2,072,670 | 8.41B |
| 72 | GH | Guardant Health, Inc. | 15.89B | 0.76% | 1,983,797 | 1.08B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.66B | -0.62% | 984,356 | 3.10B |
| 74 | THC | Tenet Healthcare Corporation | 15.19B | 1.50% | 1,217,901 | 21.46B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.90B | -1.01% | 660,156 | 4.44B |
| 76 | ASND | Ascendis Pharma A/S | 14.89B | -3.00% | 727,685 | 998.25M |
| 77 | BBIO | BridgeBio Pharma, Inc. | 13.27B | -2.01% | 2,422,752 | 579.96M |
| 78 | SOLV | Solventum Corporation | 13.21B | -0.73% | 1,068,981 | 8.26B |
| 79 | SMMT | Summit Therapeutics Inc. | 13.19B | 2.29% | 5,260,080 | - |
| 80 | SNN | Smith & Nephew plc | 13.01B | -0.33% | 1,498,451 | 6.16B |
| 81 | PEN | Penumbra, Inc. | 12.91B | -0.15% | 321,837 | 1.45B |
| 82 | IONS | Ionis Pharmaceuticals, Inc. | 12.57B | 0.67% | 1,279,225 | 1.06B |
| 83 | EXEL | Exelixis, Inc. | 12.56B | -0.34% | 2,104,267 | 2.38B |
| 84 | DVA | DaVita Inc. | 12.56B | -1.49% | 542,202 | 13.84B |
| 85 | BTSG | BrightSpring Health Services, Inc. | 12.40B | 3.11% | 2,050,397 | 13.65B |
| 86 | MEDP | Medpace Holdings, Inc. | 12.26B | -0.85% | 293,554 | 2.68B |
| 87 | COO | The Cooper Companies, Inc. | 12.10B | -0.83% | 2,000,335 | 4.15B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.09B | 1.36% | 330,935 | 1.13B |
| 89 | AXSM | Axsome Therapeutics, Inc. | 12.05B | -0.75% | 646,605 | 708.24M |
| 90 | RGC | Regencell Bioscience Holdings Limited | 12.04B | -5.78% | 179,571 | - |
| 91 | ALGN | Align Technology, Inc. | 11.71B | -0.04% | 873,542 | 4.10B |
| 92 | FMS | Fresenius Medical Care AG | 11.64B | -0.28% | 677,465 | 22.32B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.57B | 1.10% | 1,297,479 | 3.58B |
| 94 | GMED | Globus Medical, Inc. | 11.55B | 0.34% | 1,877,090 | 3.10B |
| 95 | ELAN | Elanco Animal Health Incorporated | 11.40B | 5.02% | 7,148,284 | 4.89B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.08B | 4.98% | 1,623,906 | 622.01M |
| 97 | RVTY | Revvity, Inc. | 10.80B | -0.12% | 2,453,939 | 2.90B |
| 98 | PODD | Insulet Corporation | 10.65B | -0.69% | 1,304,072 | 2.90B |
| 99 | EHC | Encompass Health Corporation | 10.41B | -0.05% | 576,874 | 6.07B |
| 100 | CYTK | Cytokinetics, Incorporated | 10.36B | -0.84% | 1,652,111 | 105.82M |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.22B | -2.24% | 1,803,788 | 3.24B |
| 102 | ABVX | ABIVAX Société Anonyme | 10.17B | 3.62% | 1,243,542 | 5.67M |
| 103 | BAX | Baxter International Inc. | 10.01B | 1.04% | 5,291,069 | 11.32B |
| 104 | ENSG | The Ensign Group, Inc. | 9.99B | 0.28% | 434,622 | 5.27B |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 9.77B | 2.05% | 384,665 | 7.46M |
| 106 | UHS | Universal Health Services, Inc. | 9.48B | -0.74% | 1,063,256 | 17.76B |
| 107 | MASI | Masimo Corporation | 9.36B | -0.08% | 910,626 | 1.56B |
| 108 | MOH | Molina Healthcare, Inc. | 9.18B | -4.31% | 1,275,731 | 43.10B |
| 109 | KRYS | Krystal Biotech, Inc. | 8.92B | 1.08% | 181,962 | 417.30M |
| 110 | ICLR | ICON Public Limited Company | 8.69B | -2.51% | 996,522 | 8.10B |
| 111 | HSIC | Henry Schein, Inc. | 8.42B | -0.42% | 1,228,547 | 13.38B |
| 112 | TEM | Tempus AI, Inc. | 8.38B | 1.04% | 4,395,771 | 1.36B |
| 113 | IBRX | ImmunityBio, Inc. | 8.30B | 9.70% | 19,077,233 | 140.98M |
| 114 | NUVL | Nuvalent, Inc. | 8.29B | 2.77% | 425,595 | - |
| 115 | HALO | Halozyme Therapeutics, Inc. | 8.15B | 0.59% | 2,031,599 | 1.51B |
| 116 | BIO | Bio-Rad Laboratories, Inc. | 7.95B | 3.18% | 454,706 | 2.59B |
| 117 | CRL | Charles River Laboratories International, Inc. | 7.55B | -2.23% | 1,120,404 | 4.03B |
| 118 | TECH | Bio-Techne Corporation | 7.51B | -0.50% | 2,588,200 | 1.21B |
| 119 | ATR | AptarGroup, Inc. | 7.43B | 0.13% | 344,534 | 3.87B |
| 120 | HQY | HealthEquity, Inc. | 7.37B | -0.98% | 777,362 | 1.31B |
| 121 | QGEN | Qiagen N.V. | 7.35B | 1.05% | 1,532,849 | 2.10B |
| 122 | PCVX | Vaxcyte, Inc. | 7.24B | 5.94% | 1,318,214 | - |
| 123 | BRKR | Bruker Corporation | 7.14B | 2.69% | 2,054,756 | 3.46B |
| 124 | IMVT | Immunovant, Inc. | 6.95B | -0.94% | 1,883,177 | - |
| 125 | GRFS | Grifols, S.A. | 6.80B | 0.38% | 487,629 | 8.58B |
| 126 | GKOS | Glaukos Corporation | 6.75B | -4.37% | 2,705,972 | 551.35M |
| 127 | KYMR | Kymera Therapeutics, Inc. | 6.64B | 2.38% | 503,076 | 51.48M |
| 128 | OSCR | Oscar Health, Inc. | 6.59B | -3.31% | 5,840,090 | 13.30B |
| 129 | CELC | Celcuity Inc. | 6.55B | -2.87% | 687,490 | - |
| 130 | LNTH | Lantheus Holdings, Inc. | 6.51B | -2.85% | 1,566,796 | 1.55B |
| 131 | RGEN | Repligen Corporation | 6.50B | 0.11% | 800,015 | 763.34M |
| 132 | CORT | Corcept Therapeutics Incorporated | 6.48B | 0.23% | 681,816 | 769.10M |
| 133 | PTGX | Protagonist Therapeutics, Inc. | 6.43B | 0.80% | 360,762 | 74.06M |
| 134 | SYRE | Spyre Therapeutics, Inc. | 6.40B | -0.54% | 478,893 | - |
| 135 | ALKS | Alkermes plc | 6.23B | 1.49% | 1,122,894 | 1.56B |
| 136 | APGE | Apogee Therapeutics, Inc. | 6.21B | 2.03% | 443,886 | - |
| 137 | SRRK | Scholar Rock Holding Corporation | 6.17B | 7.02% | 2,654,664 | - |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.16B | 2.25% | 322,665 | 217.17M |
| 139 | CNTA | Centessa Pharmaceuticals plc | 6.16B | 0.08% | 1,209,395 | 15.00M |
| 140 | PACS | PACS Group, Inc. | 6.15B | 2.97% | 669,451 | 5.43B |
| 141 | MIRM | Mirum Pharmaceuticals, Inc. | 6.03B | 0.28% | 704,598 | 569.61M |
| 142 | TFX | Teleflex Incorporated | 5.84B | -0.65% | 1,057,698 | 2.13B |
| 143 | COGT | Cogent Biosciences, Inc. | 5.80B | 3.89% | 2,815,418 | - |
| 144 | CHE | Chemed Corporation | 5.78B | -0.46% | 131,064 | 2.54B |
| 145 | TGTX | TG Therapeutics, Inc. | 5.63B | 2.21% | 1,291,538 | 700.35M |
| 146 | BLCO | Bausch + Lomb Corporation | 5.63B | -0.88% | 278,546 | 5.21B |
| 147 | PTCT | PTC Therapeutics, Inc. | 5.61B | -1.69% | 1,003,611 | 827.11M |
| 148 | BLTE | Belite Bio, Inc | 5.59B | 3.43% | 309,211 | - |
| 149 | AVTR | Avantor, Inc. | 5.56B | 0.25% | 8,443,423 | 6.55B |
| 150 | HIMS | Hims & Hers Health, Inc. | 5.52B | 0.42% | 16,605,494 | 2.37B |
| 151 | LEGN | Legend Biotech Corporation | 5.48B | 0.54% | 1,574,451 | 1.14B |
| 152 | CGON | CG Oncology, Inc. | 5.46B | -3.67% | 1,701,977 | 5.07M |
| 153 | LQDA | Liquidia Corporation | 5.34B | -1.45% | 1,287,702 | 288.07M |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 5.22B | -0.35% | 1,839,815 | 7.50M |
| 155 | CRSP | CRISPR Therapeutics AG | 4.98B | 2.44% | 1,454,909 | 4.10M |
| 156 | STVN | Stevanato Group S.p.A. | 4.91B | -0.22% | 147,163 | 1.39B |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 4.75B | 0.39% | 377,714 | 1.34M |
| 158 | LGND | Ligand Pharmaceuticals Incorporated | 4.72B | 2.62% | 222,324 | 274.48M |
| 159 | SHC | Sotera Health Company | 4.55B | 1.92% | 3,084,008 | 1.19B |
| 160 | CAI | Caris Life Sciences, Inc. | 4.39B | -0.19% | 2,004,675 | 907.29M |
| 161 | MANE | Veradermics, Incorporated | 4.28B | 0.87% | 573,423 | - |
| 162 | RDNT | RadNet, Inc. | 4.26B | -0.51% | 539,185 | 2.14B |
| 163 | NAMS | NewAmsterdam Pharma Company N.V. | 4.22B | 1.89% | 814,551 | 22.57M |
| 164 | LIVN | LivaNova PLC | 4.14B | 2.15% | 436,733 | 1.43B |
| 165 | TVTX | Travere Therapeutics, Inc. | 4.12B | -0.32% | 1,808,537 | 536.20M |
| 166 | HNGE | Hinge Health, Inc. | 4.10B | -4.11% | 1,310,005 | 646.34M |
| 167 | AMRX | Amneal Pharmaceuticals, Inc. | 4.08B | 2.98% | 2,126,192 | 3.05B |
| 168 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.07B | -0.71% | 551,346 | 754.05M |
| 169 | TWST | Twist Bioscience Corporation | 4.04B | 7.10% | 1,600,144 | 409.48M |
| 170 | BLLN | BillionToOne, Inc. | 3.89B | -1.68% | 699,196 | 354.54M |
| 171 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.88B | -0.05% | 716,518 | 18.07M |
| 172 | MMSI | Merit Medical Systems, Inc. | 3.85B | 0.55% | 713,555 | 1.54B |
| 173 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.22% | 1,565,713 | 596.96M |
| 174 | NVST | Envista Holdings Corporation | 3.82B | 0.30% | 4,642,908 | 2.81B |
| 175 | WAY | Waystar Holding Corp. | 3.78B | 0.77% | 2,869,028 | 1.16B |
| 176 | IRTC | iRhythm Holdings, Inc. | 3.76B | -1.81% | 485,611 | 787.85M |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 3.64B | 0.76% | 964,969 | 1.10B |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 3.61B | 2.63% | 1,339,160 | - |
| 179 | ERAS | Erasca, Inc. | 3.58B | 2.31% | 3,186,753 | - |
| 180 | VKTX | Viking Therapeutics, Inc. | 3.58B | -0.29% | 2,415,540 | - |
| 181 | DOCS | Doximity, Inc. | 3.57B | -2.11% | 3,261,920 | 644.86M |
| 182 | ORKA | Oruka Therapeutics, Inc. | 3.56B | -2.56% | 1,212,379 | - |
| 183 | VCYT | Veracyte, Inc. | 3.53B | -1.82% | 941,110 | 541.74M |
| 184 | OGN | Organon & Co. | 3.52B | -0.15% | 2,671,066 | 6.16B |
| 185 | ICUI | ICU Medical, Inc. | 3.37B | 1.25% | 420,695 | 2.16B |
| 186 | OPCH | Option Care Health, Inc. | 3.35B | 2.01% | 2,379,024 | 5.67B |
| 187 | ALHC | Alignment Healthcare, Inc. | 3.31B | -1.96% | 2,696,110 | 4.26B |
| 188 | CON | Concentra Group Holdings Parent, Inc. | 3.27B | 0.83% | 628,287 | 2.23B |
| 189 | BKD | Brookdale Senior Living Inc. | 3.22B | 1.35% | 2,384,643 | 3.00B |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.22B | 1.06% | 99,499 | 803.79M |
| 191 | MMED | MiniMed Group, Inc. | 3.14B | -5.81% | 521,540 | 2.99B |
| 192 | WRBY | Warby Parker Inc. | 3.13B | 1.67% | 2,808,930 | 890.57M |
| 193 | TXG | 10x Genomics, Inc. | 3.13B | 3.97% | 1,970,564 | 638.78M |
| 194 | RLAY | Relay Therapeutics, Inc. | 3.09B | 4.73% | 2,373,696 | 10.68M |
| 195 | DNLI | Denali Therapeutics Inc. | 3.08B | 3.97% | 2,354,219 | - |
| 196 | ITGR | Integer Holdings Corporation | 3.06B | 0.96% | 1,069,459 | 1.86B |
| 197 | HAE | Haemonetics Corporation | 3.04B | 2.06% | 1,049,371 | 1.33B |
| 198 | RCUS | Arcus Biosciences, Inc. | 3.03B | 2.99% | 1,110,099 | 236.00M |
| 199 | DYN | Dyne Therapeutics, Inc. | 3.00B | 4.49% | 1,686,112 | - |
| 200 | NHC | National HealthCare Corporation | 2.97B | -3.06% | 178,516 | 1.53B |
| 201 | BEAM | Beam Therapeutics Inc. | 2.97B | 4.02% | 1,411,856 | 164.01M |
| 202 | GRAL | GRAIL, Inc. | 2.96B | 2.63% | 935,643 | 156.12M |
| 203 | LFST | LifeStance Health Group, Inc. | 2.94B | 2.44% | 2,923,583 | 1.49B |
| 204 | TNGX | Tango Therapeutics, Inc. | 2.90B | -0.99% | 2,017,566 | 56.99M |
| 205 | ALMS | Alumis Inc. | 2.85B | 1.41% | 666,386 | 8.40M |
| 206 | GPCR | Structure Therapeutics Inc. | 2.81B | 1.00% | 398,894 | - |
| 207 | PRVA | Privia Health Group, Inc. | 2.80B | -2.59% | 889,457 | 2.25B |
| 208 | KLRA | Kailera Therapeutics, Inc. | 2.79B | 1.89% | 484,793 | - |
| 209 | SUPN | Supernus Pharmaceuticals, Inc. | 2.77B | -0.91% | 474,838 | 776.83M |
| 210 | ARQT | Arcutis Biotherapeutics, Inc. | 2.64B | 1.20% | 2,609,902 | 415.62M |
| 211 | TARS | Tarsus Pharmaceuticals, Inc. | 2.63B | -1.77% | 1,068,574 | 535.08M |
| 212 | IRON | Disc Medicine, Inc. | 2.60B | 1.95% | 230,641 | - |
| 213 | ELVN | Enliven Therapeutics, Inc. | 2.59B | 2.38% | 538,926 | - |
| 214 | IDYA | IDEAYA Biosciences, Inc. | 2.58B | 0.86% | 591,184 | 225.27M |
| 215 | GMRS | GMR Solutions Inc. | 2.53B | 3.09% | 711,654 | 5.74B |
| 216 | DFTX | Definium Therapeutics, Inc. | 2.50B | 1.69% | 1,350,027 | - |
| 217 | IMNM | Immunome, Inc. | 2.48B | 1.15% | 1,094,623 | 4.02M |
| 218 | MLYS | Mineralys Therapeutics, Inc. | 2.47B | 0.47% | 937,628 | - |
| 219 | VERA | Vera Therapeutics, Inc. | 2.47B | 0.88% | 682,172 | - |
| 220 | HTFL | HeartFlow, Inc. | 2.45B | -3.70% | 894,457 | 191.42M |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.44B | 0.29% | 384,923 | 1.46B |
| 222 | TMDX | TransMedics Group, Inc. | 2.44B | 2.20% | 1,555,815 | 635.89M |
| 223 | CLDX | Celldex Therapeutics, Inc. | 2.42B | 0.39% | 726,198 | 865.00K |
| 224 | PBH | Prestige Consumer Healthcare Inc. | 2.27B | 0.04% | 933,089 | 1.09B |
| 225 | RARE | Ultragenyx Pharmaceutical Inc. | 2.27B | -1.07% | 1,219,447 | 670.00M |
| 226 | ADPT | Adaptive Biotechnologies Corporation | 2.26B | 1.80% | 904,542 | 295.41M |
| 227 | LMAT | LeMaitre Vascular, Inc. | 2.26B | 0.98% | 503,761 | 256.28M |
| 228 | KOD | Kodiak Sciences Inc. | 2.25B | -0.63% | 493,428 | - |
| 229 | NKTR | Nektar Therapeutics | 2.22B | -1.58% | 880,077 | 55.63M |
| 230 | AXGN | Axogen, Inc. | 2.20B | 1.34% | 699,092 | 238.11M |
| 231 | ACHC | Acadia Healthcare Company, Inc. | 2.16B | 1.34% | 2,621,868 | 3.37B |
| 232 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.15B | 2.17% | 4,013,240 | 885.72M |
| 233 | ESTA | Establishment Labs Holdings Inc. | 2.14B | 0.62% | 654,942 | 229.58M |
| 234 | NVCR | NovoCure Limited | 2.11B | 1.67% | 1,929,521 | 674.41M |
| 235 | NBTX | Nanobiotix S.A. | 2.08B | -0.51% | 70,730 | 38.27M |
| 236 | PHVS | Pharvaris N.V. | 2.08B | 0.67% | 191,721 | - |
| 237 | ZLAB | Zai Lab Limited | 2.07B | -0.86% | 557,143 | 453.28M |
| 238 | SEM | Select Medical Holdings Corporation | 2.05B | 0.12% | 1,954,607 | 5.52B |
| 239 | TRVI | Trevi Therapeutics, Inc. | 2.04B | 1.77% | 1,077,379 | - |
| 240 | BHC | Bausch Health Companies Inc. | 2.02B | -1.28% | 1,296,707 | 10.53B |
| 241 | HCM | HUTCHMED (China) Limited | 2.02B | -2.00% | 21,670 | 548.51M |
| 242 | OMCL | Omnicell, Inc. | 2.01B | -0.70% | 399,487 | 1.23B |
| 243 | XRAY | DENTSPLY SIRONA Inc. | 2.00B | -2.15% | 5,687,437 | 3.68B |
| 244 | TYRA | Tyra Biosciences, Inc. | 2.00B | 3.45% | 568,100 | - |
| 245 | NEOG | Neogen Corporation | 1.99B | 2.70% | 3,438,403 | 870.56M |
| 246 | PGNY | Progyny, Inc. | 1.96B | 0.68% | 1,108,594 | 1.29B |
| 247 | AUPH | Aurinia Pharmaceuticals Inc. | 1.95B | -0.20% | 893,275 | 298.30M |
| 248 | SION | Sionna Therapeutics, Inc. | 1.94B | 4.25% | 188,816 | - |
| 249 | STOK | Stoke Therapeutics, Inc. | 1.93B | 5.76% | 478,418 | 32.08M |
| 250 | MESO | Mesoblast Limited | 1.93B | -1.97% | 122,186 | 65.38M |
| 251 | ASTH | Astrana Health, Inc. | 1.91B | 1.82% | 554,697 | 3.53B |
| 252 | CLOV | Clover Health Investments, Corp. | 1.90B | 1.69% | 6,931,166 | 2.21B |
| 253 | RAPP | Rapport Therapeutics, Inc. | 1.90B | 5.28% | 438,121 | 20.00M |
| 254 | ADMA | ADMA Biologics, Inc. | 1.89B | -1.09% | 3,357,678 | 509.86M |
| 255 | VRDN | Viridian Therapeutics, Inc. | 1.88B | -1.39% | 1,488,673 | 70.92M |
| 256 | ZYME | Zymeworks Inc. | 1.85B | -0.82% | 1,001,884 | 81.26M |
| 257 | AAPG | Ascentage Pharma Group International | 1.85B | -4.20% | 6,275 | 82.08M |
| 258 | IOVA | Iovance Biotherapeutics, Inc. | 1.83B | -0.24% | 14,580,816 | 285.61M |
| 259 | LKFT | Lakefront Biotherapeutics NV | 1.83B | 0.65% | 69,614 | 1.20B |
| 260 | OCUL | Ocular Therapeutix, Inc. | 1.82B | 0.73% | 2,041,844 | 52.04M |
| 261 | PLSE | Pulse Biosciences, Inc. | 1.80B | 0.42% | 185,269 | 751.00K |
| 262 | NRIX | Nurix Therapeutics, Inc. | 1.80B | -0.69% | 1,029,544 | 71.78M |
| 263 | VCEL | Vericel Corporation | 1.79B | 0.69% | 465,457 | 292.09M |
| 264 | UFPT | UFP Technologies, Inc. | 1.77B | 0.04% | 220,097 | 608.85M |
| 265 | OCS | Oculis Holding AG | 1.77B | 1.49% | 273,597 | 1.40M |
| 266 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -0.20% | 850,098 | 217.17M |
| 267 | NTLA | Intellia Therapeutics, Inc. | 1.76B | 0.08% | 3,623,186 | 66.09M |
| 268 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | -0.77% | 3,092,835 | 2.18B |
| 269 | SNDA | Sonida Senior Living, Inc. | 1.75B | 1.38% | 749,858 | 367.34M |
| 270 | SGRY | Surgery Partners, Inc. | 1.74B | 0.37% | 1,256,582 | 3.34B |
| 271 | HRMY | Harmony Biosciences Holdings, Inc. | 1.74B | -0.20% | 699,205 | 899.11M |
| 272 | MD | Pediatrix Medical Group, Inc. | 1.73B | 1.41% | 711,136 | 1.93B |
| 273 | ANIP | ANI Pharmaceuticals, Inc. | 1.73B | -1.58% | 456,073 | 923.71M |
| 274 | NVAX | Novavax, Inc. | 1.72B | 13.57% | 8,324,001 | 596.34M |
| 275 | GENB | Generate Biomedicines, Inc. | 1.71B | -8.19% | 1,041,499 | 30.30M |
| 276 | ADUS | Addus HomeCare Corporation | 1.70B | 0.57% | 179,409 | 1.45B |
| 277 | CAPR | Capricor Therapeutics, Inc. | 1.70B | 1.70% | 674,651 | 11.13M |
| 278 | PVLA | Palvella Therapeutics, Inc. | 1.69B | 3.16% | 126,735 | - |
| 279 | AGIO | Agios Pharmaceuticals, Inc. | 1.68B | 0.68% | 903,181 | 66.05M |
| 280 | ANAB | AnaptysBio, Inc. | 1.68B | -3.25% | 482,157 | 232.39M |
| 281 | INVA | Innoviva, Inc. | 1.67B | 0.98% | 901,782 | 420.69M |
| 282 | STAA | STAAR Surgical Company | 1.66B | 2.68% | 955,308 | 290.38M |
| 283 | CMPS | COMPASS Pathways plc | 1.65B | 3.51% | 3,881,380 | - |
| 284 | NUVB | Nuvation Bio Inc. | 1.63B | -0.64% | 2,719,658 | 143.05M |
| 285 | GLUE | Monte Rosa Therapeutics, Inc. | 1.62B | 2.07% | 697,547 | 42.95M |
| 286 | ABCL | AbCellera Biologics Inc. | 1.61B | 1.73% | 8,717,599 | 79.21M |
| 287 | TSHA | Taysha Gene Therapies, Inc. | 1.61B | 1.82% | 2,729,531 | 7.47M |
| 288 | DMRA | Damora Therapeutics, Inc. | 1.59B | 2.33% | 346,109 | - |
| 289 | GHRS | GH Research PLC | 1.59B | 4.66% | 340,940 | - |
| 290 | QURE | uniQure N.V. | 1.59B | 3.97% | 1,222,414 | 18.09M |
| 291 | AVAH | Aveanna Healthcare Holdings Inc. | 1.59B | -0.68% | 1,511,078 | 2.52B |
| 292 | VIR | Vir Biotechnology, Inc. | 1.58B | 2.07% | 1,154,006 | 65.50M |
| 293 | RXRX | Recursion Pharmaceuticals, Inc. | 1.58B | -1.33% | 29,619,806 | 66.41M |
| 294 | ATAI | AtaiBeckley Inc. | 1.57B | -0.69% | 4,592,618 | 3.49M |
| 295 | INBX | Inhibrx Biosciences, Inc. | 1.57B | 5.46% | 228,829 | 1.30M |
| 296 | PRCT | PROCEPT BioRobotics Corporation | 1.56B | -5.34% | 1,452,297 | 322.02M |
| 297 | ARDX | Ardelyx, Inc. | 1.54B | 2.29% | 2,605,400 | 427.68M |
| 298 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.52B | 0.74% | 674,426 | -665.00K |
| 299 | BHVN | Biohaven Ltd. | 1.52B | 6.56% | 2,222,279 | - |
| 300 | PGEN | Precigen, Inc. | 1.51B | - | 6,099,107 | 31.60M |
| 301 | MBX | MBX Biosciences, Inc. | 1.51B | -0.31% | 247,656 | - |
| 302 | SLS | SELLAS Life Sciences Group, Inc. | 1.51B | 4.37% | 8,743,374 | - |
| 303 | IMTX | Immatics N.V. | 1.50B | -3.70% | 670,038 | 43.00M |
| 304 | IMCR | Immunocore Holdings plc | 1.50B | 2.01% | 385,633 | 412.81M |
| 305 | PRGO | Perrigo Company plc | 1.49B | -3.74% | 3,061,038 | 4.18B |
| 306 | WGS | GeneDx Holdings Corp. | 1.47B | 4.50% | 913,030 | 442.68M |
| 307 | ATRC | AtriCure, Inc. | 1.46B | 1.84% | 1,120,689 | 552.16M |
| 308 | MAZE | Maze Therapeutics, Inc. | 1.46B | 2.21% | 495,105 | 20.00M |
| 309 | NNNN | Anbio Biotechnology | 1.45B | 1.51% | 30,421 | 8.65M |
| 310 | BCAX | Bicara Therapeutics Inc. | 1.44B | 1.38% | 555,042 | - |
| 311 | URGN | UroGen Pharma Ltd. | 1.44B | 1.97% | 611,170 | 140.49M |
| 312 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.07% | 8,068,131 | 114.48M |
| 313 | AGL | agilon health, inc. | 1.42B | -1.30% | 298,058 | 5.82B |
| 314 | ENOV | Enovis Corporation | 1.40B | 0.37% | 1,161,170 | 2.28B |
| 315 | HCSG | Healthcare Services Group, Inc. | 1.39B | -0.54% | 1,009,499 | 1.85B |
| 316 | SEPN | Septerna, Inc. | 1.38B | 8.06% | 347,396 | 72.26M |
| 317 | AHCO | AdaptHealth Corp. | 1.38B | -0.86% | 826,663 | 3.29B |
| 318 | AHG | Akso Health Group | 1.37B | 4.58% | 15,249 | 14.84M |
| 319 | PAHC | Phibro Animal Health Corporation | 1.37B | 1.26% | 322,343 | 1.50B |
| 320 | MPLT | MapLight Therapeutics, Inc. | 1.34B | 2.47% | 211,970 | - |
| 321 | ARDT | Ardent Health, Inc. | 1.33B | 0.65% | 284,535 | 6.43B |
| 322 | MLTX | MoonLake Immunotherapeutics | 1.33B | 0.22% | 575,313 | - |
| 323 | ALMR | Alamar Biosciences, Inc. | 1.32B | -4.84% | 388,205 | 87.16M |
| 324 | SVRA | Savara Inc. | 1.30B | 2.39% | 695,509 | - |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.30B | 4.53% | 552,294 | - |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.27B | 0.83% | 301,396 | 83.72M |
| 327 | HROW | Harrow, Inc. | 1.27B | 3.55% | 994,102 | 268.68M |
| 328 | FTRE | Fortrea Holdings Inc. | 1.25B | - | 1,136,082 | 2.71B |
| 329 | ATEC | Alphatec Holdings, Inc. | 1.24B | -2.54% | 2,794,375 | 787.08M |
| 330 | COAG | Hemab Therapeutics Holdings, Inc. | 1.23B | 7.53% | 271,179 | - |
| 331 | WVE | Wave Life Sciences Ltd. | 1.23B | - | 2,457,584 | 71.80M |
| 332 | INSP | Inspire Medical Systems, Inc. | 1.21B | -4.22% | 1,461,450 | 915.25M |
| 333 | NEO | NeoGenomics, Inc. | 1.21B | 0.43% | 850,485 | 745.97M |
| 334 | TDOC | Teladoc Health, Inc. | 1.19B | 0.30% | 3,857,139 | 2.51B |
| 335 | IRMD | IRADIMED CORPORATION | 1.19B | 0.91% | 102,263 | 86.28M |
| 336 | BFLY | Butterfly Network, Inc. | 1.19B | 1.57% | 2,999,481 | 102.92M |
| 337 | OLMA | Olema Pharmaceuticals, Inc. | 1.18B | -0.95% | 1,081,736 | - |
| 338 | ZBIO | Zenas BioPharma, Inc. | 1.18B | -1.27% | 407,734 | 10.00M |
| 339 | IART | Integra LifeSciences Holdings Corporation | 1.18B | 0.60% | 842,220 | 1.64B |
| 340 | PNTG | The Pennant Group, Inc. | 1.18B | - | 148,088 | 1.02B |
| 341 | BLFS | BioLife Solutions, Inc. | 1.17B | 0.33% | 754,866 | 101.66M |
| 342 | AVNS | Avanos Medical, Inc. | 1.16B | 0.57% | 1,167,935 | 715.90M |
| 343 | AKTS | Aktis Oncology, Inc. | 1.14B | 1.18% | 166,089 | 8.28M |
| 344 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.13B | -0.45% | 5,118,784 | 204.73M |
| 345 | AORT | Artivion, Inc. | 1.13B | 3.25% | 534,110 | 458.69M |
| 346 | EYPT | EyePoint, Inc. | 1.12B | 3.25% | 918,191 | 7.61M |
| 347 | AVLN | Avalyn Pharma Inc. | 1.12B | -7.42% | 367,899 | - |
| 348 | CDNA | CareDx, Inc. | 1.11B | -0.42% | 476,915 | 412.82M |
| 349 | DBVT | DBV Technologies S.A. | 1.11B | -0.11% | 175,219 | 5.74M |
| 350 | IVA | Inventiva S.A. | 1.10B | 1.78% | 127,282 | 7.94M |
| 351 | COLL | Collegium Pharmaceutical, Inc. | 1.10B | -0.85% | 283,711 | 796.33M |
| 352 | MNKD | MannKind Corporation | 1.09B | 4.44% | 3,704,851 | 360.78M |
| 353 | CNMD | CONMED Corporation | 1.09B | -3.14% | 344,389 | 1.37B |
| 354 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | 1.13% | 972,746 | 314.85M |
| 355 | CRVS | Corvus Pharmaceuticals, Inc. | 1.08B | 1.74% | 844,135 | - |
| 356 | JBIO | Jade Biosciences, Inc. | 1.07B | -2.25% | 606,403 | - |
| 357 | ALVO | Alvotech | 1.07B | 2.40% | 468,893 | 562.04M |
| 358 | AMN | AMN Healthcare Services, Inc. | 1.06B | -1.59% | 728,378 | 3.42B |
| 359 | EVO | Evotec SE | 1.03B | -3.96% | 22,012 | 859.03M |
| 360 | CRON | Cronos Group Inc. | 1.02B | -0.36% | 1,096,667 | 159.54M |
| 361 | INNV | InnovAge Holding Corp. | 997.66M | 2.08% | 233,473 | 949.17M |
| 362 | TNDM | Tandem Diabetes Care, Inc. | 996.41M | -2.87% | 2,845,800 | 1.03B |
| 363 | SDGR | Schrödinger, Inc. | 982.58M | -1.13% | 1,020,229 | 254.91M |
| 364 | OPK | OPKO Health, Inc. | 974.07M | 1.57% | 2,466,959 | 581.12M |
| 365 | PHAR | Pharming Group N.V. | 973.18M | 8.10% | 31,406 | 369.49M |
| 366 | PCRX | Pacira BioSciences, Inc. | 958.52M | 4.33% | 635,904 | 734.86M |
| 367 | OMDA | Omada Health, Inc. | 957.12M | -2.48% | 516,432 | 283.30M |
| 368 | SPTX | Seaport Therapeutics, Inc. | 955.03M | 2.91% | 181,098 | - |
| 369 | CGEM | Cullinan Therapeutics, Inc. | 950.14M | 11.71% | 964,780 | - |
| 370 | USPH | U.S. Physical Therapy, Inc. | 945.24M | 0.24% | 158,083 | 787.69M |
| 371 | AZTA | Azenta, Inc. | 944.90M | 1.59% | 957,155 | 596.48M |
| 372 | GDRX | GoodRx Holdings, Inc. | 941.52M | 4.91% | 3,245,148 | 787.89M |
| 373 | PSNL | Personalis, Inc. | 936.21M | 5.55% | 2,391,627 | 64.52M |
| 374 | DRTS | Alpha Tau Medical Ltd. | 935.13M | 3.29% | 796,507 | - |
| 375 | KURA | Kura Oncology, Inc. | 924.14M | -7.47% | 2,932,514 | 71.64M |
| 376 | AVR | Anteris Technologies Global Corp. | 923.72M | -5.61% | 1,613,887 | 1.85M |
| 377 | ABUS | Arbutus Biopharma Corporation | 916.57M | 6.67% | 2,327,238 | 191.45M |
| 378 | LXRX | Lexicon Pharmaceuticals, Inc. | 914.85M | -4.63% | 3,074,558 | 69.64M |
| 379 | ANNX | Annexon, Inc. | 904.41M | 3.95% | 4,504,766 | - |
| 380 | MGTX | MeiraGTx Holdings plc | 889.05M | 3.90% | 619,283 | 79.76M |
| 381 | ORIC | ORIC Pharmaceuticals, Inc. | 884.04M | 2.64% | 913,811 | - |
| 382 | PHAT | Phathom Pharmaceuticals, Inc. | 881.67M | -2.03% | 834,488 | 204.89M |
| 383 | JANX | Janux Therapeutics, Inc. | 878.17M | -0.83% | 365,204 | 13.73M |
| 384 | INMD | InMode Ltd. | 874.98M | 0.51% | 1,193,032 | 374.64M |
| 385 | TALK | Talkspace, Inc. | 871.07M | - | 1,557,034 | 238.37M |
| 386 | XNCR | Xencor, Inc. | 862.27M | 2.83% | 526,296 | 97.36M |
| 387 | ETON | Eton Pharmaceuticals, Inc. | 857.11M | -3.99% | 361,144 | 86.93M |
| 388 | SANA | Sana Biotechnology, Inc. | 848.79M | -0.65% | 4,075,545 | - |
| 389 | NUTX | Nutex Health Inc. | 847.78M | 3.61% | 152,298 | 879.95M |
| 390 | TBPH | Theravance Biopharma, Inc. | 845.98M | 0.24% | 434,113 | 109.78M |
| 391 | OMER | Omeros Corporation | 843.17M | 1.66% | 1,170,484 | 9.89M |
| 392 | AVTX | Avalo Therapeutics, Inc. | 842.10M | -2.02% | 1,381,387 | 59.00K |
| 393 | EVMN | Evommune, Inc. | 841.03M | 2.10% | 392,871 | 10.00M |
| 394 | AURA | Aura Biosciences, Inc. | 839.38M | 0.13% | 276,838 | - |
| 395 | AMPH | Amphastar Pharmaceuticals, Inc. | 829.39M | 2.17% | 670,766 | 720.53M |
| 396 | DRUG | Bright Minds Biosciences Inc. | 828.73M | 3.33% | 199,104 | - |
| 397 | ODTX | Odyssey Therapeutics, Inc. | 828.38M | 0.34% | 400,111 | 2.98M |
| 398 | ABSI | Absci Corporation | 823.18M | 3.53% | 3,048,614 | 1.84M |
| 399 | GERN | Geron Corporation | 821.15M | - | 10,873,596 | 196.12M |
| 400 | QDEL | QuidelOrtho Corporation | 817.61M | 1.10% | 1,335,403 | 2.66B |
| 401 | LBRX | LB Pharmaceuticals Inc | 812.41M | 0.75% | 128,957 | - |
| 402 | SPRY | ARS Pharmaceuticals, Inc. | 811.31M | 2.90% | 1,060,977 | 98.99M |
| 403 | CERT | Certara, Inc. | 810.49M | -0.57% | 4,426,756 | 419.75M |
| 404 | CTMX | CytomX Therapeutics, Inc. | 803.32M | -1.86% | 2,542,552 | 35.54M |
| 405 | ESPR | Esperion Therapeutics, Inc. | 803.19M | -0.32% | 6,813,107 | 418.24M |
| 406 | LMRI | Lumexa Imaging Holdings, Inc. | 784.98M | 2.12% | 595,086 | 1.03B |
| 407 | VOR | Vor Biopharma Inc. | 764.02M | -1.61% | 685,987 | - |
| 408 | BVS | Bioventus Inc. | 753.48M | -2.80% | 781,437 | 576.30M |
| 409 | RLMD | Relmada Therapeutics, Inc. | 752.05M | 1.85% | 726,375 | - |
| 410 | SSII | SS Innovations International, Inc. | 745.78M | -4.11% | 82,792 | 48.47M |
| 411 | ANRO | Alto Neuroscience, Inc. | 738.21M | -0.75% | 413,618 | - |
| 412 | ALLO | Allogene Therapeutics, Inc. | 731.73M | 6.00% | 4,770,341 | 22.00K |
| 413 | BIOA | BioAge Labs, Inc. | 720.13M | -2.47% | 586,314 | 10.32M |
| 414 | CBLL | CeriBell, Inc. | 713.32M | 0.16% | 187,155 | 95.07M |
| 415 | DSGN | Design Therapeutics, Inc. | 712.01M | 3.92% | 1,035,825 | - |
| 416 | HSTM | HealthStream, Inc. | 711.97M | 2.35% | 171,377 | 311.78M |
| 417 | TENX | Tenax Therapeutics, Inc. | 705.36M | -1.24% | 353,003 | - |
| 418 | SGP | SpyGlass Pharma, Inc. | 689.26M | -1.06% | 86,575 | - |
| 419 | SLDB | Solid Biosciences Inc. | 677.33M | 3.93% | 790,771 | - |
| 420 | CBIO | Crescent Biopharma, Inc. | 676.21M | -1.88% | 326,381 | 11.88M |
| 421 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 670.50M | -2.11% | 416,463 | - |
| 422 | SIBN | SI-BONE, Inc. | 650.60M | -0.07% | 481,205 | 206.22M |
| 423 | TLRY | Tilray Brands, Inc. | 650.09M | 3.02% | 2,955,707 | 858.28M |
| 424 | CRMD | CorMedix Inc. | 648.80M | 3.63% | 1,313,577 | 400.05M |
| 425 | BWAY | BrainsWay Ltd. | 645.55M | 5.23% | 163,047 | 56.22M |
| 426 | IRWD | Ironwood Pharmaceuticals, Inc. | 641.99M | -0.51% | 2,785,384 | 361.51M |
| 427 | ACRS | Aclaris Therapeutics, Inc. | 629.88M | -0.22% | 718,192 | 8.37M |
| 428 | IMMX | Immix Biopharma, Inc. | 616.95M | 0.68% | 3,651,400 | - |
| 429 | ZVRA | Zevra Therapeutics, Inc. | 610.07M | 2.89% | 1,853,522 | 122.29M |
| 430 | CABA | Cabaletta Bio, Inc. | 606.56M | 1.92% | 2,415,531 | - |
| 431 | CSTL | Castle Biosciences, Inc. | 597.20M | -2.28% | 401,929 | 339.92M |
| 432 | TRAX | First Tracks Biotherapeutics, Inc. | 595.09M | -0.73% | 290,822 | - |
| 433 | CADL | Candel Therapeutics, Inc. | 582.50M | -0.50% | 1,320,174 | - |
| 434 | ARVN | Arvinas, Inc. | 575.53M | -1.87% | 636,575 | 89.40M |
| 435 | ALT | Altimmune, Inc. | 569.81M | 1.03% | 2,154,110 | 36.00K |
| 436 | NPCE | NeuroPace, Inc. | 568.68M | -1.42% | 109,713 | 99.53M |
| 437 | DNA | Ginkgo Bioworks Holdings, Inc. | 567.67M | 3.33% | 954,229 | 151.40M |
| 438 | VALN | Valneva SE | 567.60M | 2.02% | 21,941 | 180.25M |
| 439 | TECX | Tectonic Therapeutic, Inc. | 565.89M | 2.99% | 367,462 | - |
| 440 | TCMD | Tactile Systems Technology, Inc. | 565.26M | 0.64% | 357,184 | 343.52M |
| 441 | ASMB | Assembly Biosciences, Inc. | 553.47M | 1.45% | 244,658 | 71.10M |
| 442 | CERS | Cerus Corporation | 547.01M | 0.74% | 1,174,053 | 216.56M |
| 443 | MDXG | MiMedx Group, Inc. | 546.63M | 1.38% | 2,192,202 | 389.42M |
| 444 | AGMB | AgomAb Therapeutics NV | 544.19M | -3.91% | 87,435 | - |
| 445 | CLYM | Climb Bio, Inc. | 544.08M | 3.55% | 676,541 | - |
| 446 | PHR | Phreesia, Inc. | 543.83M | 0.34% | 1,269,389 | 480.59M |
| 447 | GYRE | Gyre Therapeutics, Inc. | 542.75M | -1.98% | 125,949 | 117.05M |
| 448 | RIGL | Rigel Pharmaceuticals, Inc. | 539.71M | 0.55% | 441,641 | 299.77M |
| 449 | PRME | Prime Medicine, Inc. | 536.43M | - | 2,332,390 | 4.03M |
| 450 | FBRX | Forte Biosciences, Inc. | 536.12M | 1.62% | 205,052 | - |
| 451 | EIKN | Eikon Therapeutics, Inc. | 535.97M | -9.26% | 402,427 | - |
| 452 | SRTA | Strata Critical Medical, Inc. | 531.27M | 0.16% | 983,616 | 228.58M |
| 453 | PRTA | Prothena Corporation plc | 526.67M | 2.34% | 918,666 | 57.94M |
| 454 | XOMA | XOMA Royalty Corporation | 523.21M | 0.17% | 67,599 | 48.56M |
| 455 | BBNX | Beta Bionics, Inc. | 522.26M | -0.85% | 796,088 | 110.24M |
| 456 | KYTX | Kyverna Therapeutics, Inc. | 521.17M | -0.69% | 981,955 | - |
| 457 | CTKB | Cytek Biosciences, Inc. | 512.70M | -1.00% | 803,429 | 204.17M |
| 458 | CTNM | Contineum Therapeutics, Inc. | 512.19M | -1.15% | 209,883 | - |
| 459 | AQST | Aquestive Therapeutics, Inc. | 511.84M | -0.97% | 1,051,733 | 50.27M |
| 460 | PROK | ProKidney Corp. | 510.48M | -3.43% | 896,542 | 889.00K |
| 461 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 462 | FLGT | Fulgent Genetics, Inc. | 501.84M | 3.27% | 622,380 | 320.35M |
| 463 | ANGO | AngioDynamics, Inc. | 491.85M | -1.01% | 418,815 | 313.73M |
| 464 | EPRX | Eupraxia Pharmaceuticals Inc. | 488.65M | 6.06% | 360,491 | - |
| 465 | CATX | Perspective Therapeutics, Inc. | 474.43M | 4.52% | 1,521,864 | 618.00K |
| 466 | EBS | Emergent BioSolutions Inc. | 471.07M | 8.05% | 1,085,043 | 676.80M |
| 467 | STTK | Shattuck Labs, Inc. | 468.52M | 0.16% | 440,091 | 1.00M |
| 468 | ACHV | Achieve Life Sciences, Inc. | 468.13M | -2.77% | 1,039,781 | - |
| 469 | KMDA | Kamada Ltd. | 464.80M | 1.53% | 92,481 | 181.68M |
| 470 | KIDS | OrthoPediatrics Corp. | 459.76M | -2.56% | 116,199 | 243.30M |
| 471 | TOI | The Oncology Institute, Inc. | 458.92M | - | 1,667,026 | 545.76M |
| 472 | FDMT | 4D Molecular Therapeutics, Inc. | 455.33M | 1.28% | 393,064 | 88.24M |
| 473 | ANL | Adlai Nortye Ltd. | 454.00M | -4.78% | 61,666 | 5.00M |
| 474 | STRO | Sutro Biopharma, Inc. | 453.63M | 7.08% | 643,045 | 99.61M |
| 475 | OCGN | Ocugen, Inc. | 453.62M | - | 5,568,075 | 4.47M |
| 476 | FULC | Fulcrum Therapeutics, Inc. | 450.44M | 2.89% | 375,124 | 80.00M |
| 477 | WEAV | Weave Communications, Inc. | 447.95M | -1.40% | 658,725 | 248.72M |
| 478 | AUTL | Autolus Therapeutics plc | 447.12M | -1.18% | 1,071,336 | 92.62M |
| 479 | UPB | Upstream Bio, Inc. | 446.79M | -1.91% | 593,003 | 3.32M |
| 480 | ADCT | ADC Therapeutics SA | 446.44M | 3.54% | 793,909 | 79.18M |
| 481 | SGMT | Sagimet Biosciences Inc. | 445.85M | 1.83% | 909,660 | - |
| 482 | MOBI | Mobia Medical, Inc. | 435.40M | 4.44% | 132,310 | 32.04M |
| 483 | EVH | Evolent Health, Inc. | 430.80M | -3.04% | 1,553,581 | 1.89B |
| 484 | NRC | NRC Health | 429.10M | -0.21% | 90,670 | 138.64M |
| 485 | VREX | Varex Imaging Corporation | 428.63M | 0.99% | 285,521 | 857.50M |
| 486 | NGNE | Neurogene Inc. | 428.23M | -2.20% | 156,113 | 925.00K |
| 487 | LAB | Standard BioTools Inc. | 425.50M | 5.83% | 2,317,379 | 86.26M |
| 488 | OVID | Ovid Therapeutics Inc. | 423.94M | -0.81% | 1,096,281 | 7.12M |
| 489 | MNPR | Monopar Therapeutics Inc. | 419.48M | -0.79% | 165,443 | - |
| 490 | EOLS | Evolus, Inc. | 411.59M | 2.63% | 868,468 | 301.79M |
| 491 | VTVT | vTv Therapeutics Inc. | 411.50M | -3.63% | 58,208 | 36.84M |
| 492 | PRLD | Prelude Therapeutics Incorporated | 411.36M | -4.22% | 311,103 | 16.72M |
| 493 | CCRN | Cross Country Healthcare, Inc. | 405.59M | 0.23% | 323,908 | 1.00B |
| 494 | LXEO | Lexeo Therapeutics, Inc. | 403.60M | 0.59% | 601,570 | - |
| 495 | IFRX | InflaRx N.V. | 403.58M | 4.98% | 1,644,815 | 33.82K |
| 496 | CGC | Canopy Growth Corporation | 399.84M | 0.96% | 8,522,785 | 203.04M |
| 497 | ZURA | Zura Bio Limited | 399.45M | -3.44% | 490,409 | - |
| 498 | CMPX | Compass Therapeutics, Inc. | 396.19M | 6.28% | 4,729,744 | 850.00K |
| 499 | OFIX | Orthofix Medical Inc. | 394.92M | -9.12% | 981,249 | 825.37M |
| 500 | ENTA | Enanta Pharmaceuticals, Inc. | 393.43M | -3.01% | 330,510 | 69.21M |